Silibinin Upregulates CXCR4 Expression in Cultured Bone Marrow Cells (BMCs) Especially in Pulmonary Arterial Hypertension Rat Model
Previously we reported that silibinin ameliorated pulmonary arterial hypertension (PAH) in rat PAH models, possibly through the suppression of the CXCR4/SDF-1, until the point where PAH became a severe and irreversible condition. To further investigate how silibinin ameliorates PAH, we first attempt...
Main Authors: | Tingting Zhang, Nanako Kawaguchi, Kunikazu Tsuji, Emiko Hayama, Yoshiyuki Furutani, Hisashi Sugiyama, Toshio Nakanishi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/5/1276 |
Similar Items
-
Monocytes from preeclamptic women previously treated with silibinin attenuate oxidative stress in human endothelial cells
by: Virgínia Juliani Gomes, et al.
Published: (2021-04-01) -
An Overview on the Effects of Silibinin on Different MicroRNAs Expression in Cancer
by: Vahid Akbari Kordkheyli, et al.
Published: (2018-10-01) -
Involvement of CXCR4 in Normal and Abnormal Development
by: Nanako Kawaguchi, et al.
Published: (2019-02-01) -
Silibinin upregulates E-cadherin expression in MKN-45 human gastric cancer cells
by: Ebrahim Faghihloo*, et al.
Published: (2018-06-01) -
Inhibition of Phagocytosis by Silibinin in Mouse Macrophages
by: Kyung-Hoon Sun, et al.
Published: (2023-10-01)